These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 19264574

  • 1. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
    Arts J, Caenepeel P, Bisschops R, Dewulf D, Holvoet L, Piessevaux H, Bourgeois S, Sifrim D, Janssens J, Tack J.
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):432-7. PubMed ID: 19264574
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C, Vecht J, Masclee AA.
    Aliment Pharmacol Ther; 2005 Nov 15; 22(10):963-9. PubMed ID: 16268971
    [Abstract] [Full Text] [Related]

  • 3. Octreotide therapy in dumping syndrome: Analysis of long-term results.
    Didden P, Penning C, Masclee AA.
    Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1367-75. PubMed ID: 17059518
    [Abstract] [Full Text] [Related]

  • 4. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients.
    Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP.
    J Clin Rheumatol; 2007 Jun 01; 13(3):119-23. PubMed ID: 17551375
    [Abstract] [Full Text] [Related]

  • 5. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
    Mystakidou K, Katsouda E, Tsilika E, Smyrniotis V, Vassiliou I, Tsiatas M, Vlahos L.
    Anticancer Res; 2006 Jun 01; 26(3B):2325-8. PubMed ID: 16821610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A pilot study of the effects of the somatostatin analog pasireotide in postoperative dumping syndrome.
    Deloose E, Bisschops R, Holvoet L, Arts J, De Wulf D, Caenepeel P, Lannoo M, Vanuytsel T, Andrews C, Tack J.
    Neurogastroenterol Motil; 2014 Jun 01; 26(6):803-9. PubMed ID: 24750284
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Postgastrectomy dumping treated with octreotide (Sandostatin)].
    Møller TD, Carlsen CU.
    Ugeskr Laeger; 1993 Jun 07; 155(23):1805-6. PubMed ID: 8317033
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children.
    O'Meara M, Cicalese MP, Bordugo A, Ambrosi A, Hadzic N, Mieli-Vergani G.
    J Pediatr Gastroenterol Nutr; 2015 Jan 07; 60(1):48-53. PubMed ID: 25162361
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun 07; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.
    Oberg K.
    Expert Rev Anticancer Ther; 2009 May 07; 9(5):557-66. PubMed ID: 19445573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.